(Q33763351)

29 July 2017

1 reference

title

Progressive multifocal leukoencephalopathy and other forms of JC virus disease (English)

1 reference

progressive multifocal leukoencephalopathy

29 July 2017

0 references

1

Bruce J Brew

1 reference

29 July 2017

Nicholas W S Davies

2

1 reference

29 July 2017

Paola Cinque

series ordinal

3

1 reference

29 July 2017

David B Clifford

series ordinal

4

1 reference

29 July 2017

Avindra Nath

series ordinal

5

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 December 2010

1 reference

29 July 2017

Nature Reviews Neurology

1 reference

29 July 2017

6

1 reference

29 July 2017

12

1 reference

29 July 2017

667-679

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2010.164

29 July 2017

0 references

cites work

Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Progressive multifocal leukoencephalopathy in HIV-1 infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

An overview: Human Polyomavirus JC Virus and its Associated Disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Polyomavirus JCV excretion and genotype analysis in HIV-infected patients receiving highly active antiretroviral therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Progressive multifocal leukoencephalopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Changing incidence of central nervous system diseases in the EuroSIDA cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

AIDS- and non-AIDS-related PML association with distinct p53 polymorphism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Progressive multifocal leukoencephalitis (PML) in three patients treated with standard-dose fludarabine (FAMP)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Immune response in progressive multifocal leukoencephalopathy: an overview

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Progressive multifocal leukoencephalopathy in patients with HIV infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Progressive multifocal leukoencephalopathy in rheumatic diseases: evolving clinical and pathologic patterns of disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Progressive multifocal leukoencephalopathy: report of three cases in HIV-negative hematological patients and review of literature.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Infectious Complications Associated with Alemtuzumab Use for Lymphoproliferative Disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Role of the environment in the transmission of JC virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

The human polyomavirus, JCV, uses serotonin receptors to infect cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Reactivation of JC virus and development of PML in patients with multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Traffic of JC virus from sites of initial infection to the brain: the path to progressive multifocal leukoencephalopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Progressive multifocal leukoencephalopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Adaptive mutations in the JC virus protein capsid are associated with progressive multifocal leukoencephalopathy (PML)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Progressive multifocal leukoencephalopathy revisited: Has the disease outgrown its name?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Frequent infection of cerebellar granule cell neurons by polyomavirus JC in progressive multifocal leukoencephalopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Fulminant JC virus encephalopathy with productive infection of cortical pyramidal neurons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Detection of archetype and rearranged variants of JC virus in multiple tissues from a pediatric PML patient

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Archetypal and rearranged sequences of human polyomavirus JC transcription control region in peripheral blood leukocytes and in cerebrospinal fluid.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Identical rearranged forms of JC polyomavirus transcriptional control region in plasma and cerebrospinal fluid of acquired immunodeficiency syndrome patients with progressive multifocal leukoencephalopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

JC virus regulatory region tandem repeats in plasma and central nervous system isolates correlate with poor clinical outcome in patients with progressive multifocal leukoencephalopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Detection of JC virus DNA fragments but not proteins in normal brain tissue.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Integrin-mediated long-term B cell retention in the splenic marginal zone.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Alpha4 integrins regulate the proliferation/differentiation balance of multilineage hematopoietic progenitors in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Asymptomatic reactivation of JC virus in patients treated with natalizumab

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

"Thinking without thinking" about natalizumab and PML.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Polyomavirus JC infects human brain microvascular endothelial cells independent of serotonin receptor 2A.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Progressive multifocal leukoencephalopathy presenting as human immunodeficiency virus type 1 (HIV)-associated dementia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Seizures and their outcome in progressive multifocal leukoencephalopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Spinal cord lesions of progressive multifocal leukoencephalopathy in an acquired immunodeficiency syndrome patient.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Progressive multifocal leukoencephalopathy: diffusion-weighted imaging and pathological correlations.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Metabolite abnormalities in progressive multifocal leukoencephalopathy by proton magnetic resonance spectroscopy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

JCV-DNA and BKV-DNA in the CNS tissue and CSF of AIDS patients and normal subjects. Study of 41 cases and review of the literature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Comparison of PCR-southern hybridization and quantitative real-time PCR for the detection of JC and BK viral nucleotide sequences in urine and cerebrospinal fluid

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Diagnosis of central nervous system complications in HIV-infected patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

False negative PCR despite high levels of JC virus DNA in spinal fluid: Implications for diagnostic testing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

JC virus in cerebrospinal fluid samples of multiple sclerosis patients at the first demyelinating event.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Detection of CSF-specific oligoclonal antibodies to recombinant JC virus VP1 in patients with progressive multifocal leukoencephalopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

The JC virus antibody response in serum and cerebrospinal fluid in progressive multifocal leucoencephalopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Progressive multifocal leukoencephalopathy: simultaneous detection of JCV DNA and anti-JCV antibodies in the cerebrospinal fluid

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

New insights into progressive multifocal leukoencephalopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Progressive multifocal leukoencephalopathy: a retrospective study of 30 cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Detection of JC virus DNA in the peripheral blood leukocytes of HIV-infected patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Asymptomatic reactivation of JC virus in patients treated with natalizumab

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Progressive multifocal leukoencephalopathy in transplant recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Successful outcome of progressive multifocal leukoencephalopathy in a renal transplant patient

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Advances in the biology of JC virus and induction of progressive multifocal leukoencephalopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Opportunistic infections of the CNS in patients with AIDS: diagnosis and management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Clinical uses of cidofovir

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Progressive multifocal leukoencephalopathy-remission with cytarabine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Survival prolongation in HIV-associated progressive multifocal leukoencephalopathy treated with alpha-interferon: an observational study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Interferon- alpha and - beta restrict polyomavirus JC replication in primary human fetal glial cells: implications for progressive multifocal leukoencephalopathy therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Progressive multifocal leukoencephalopathy in a haploidentical stem cell transplant recipient: a clinical, neuroradiological and virological response after treatment with risperidone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Serotonin receptor 2A blocker (risperidone) has no effect on human polyomavirus JC infection of primary human fetal glial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Efficient in vitro expansion of JC virus-specific CD8(+) T-cell responses by JCV peptide-stimulated dendritic cells from patients with progressive multifocal leukoencephalopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation and alpha-interferon immunotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Sustained recovery of progressive multifocal leukoencephalopathy after treatment with IL-2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Successful treatment of progressive multifocal leukoencephalopathy with low-dose interleukin-2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Interleukin-2 therapy in patients with HIV infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Identification and characterization of mefloquine efficacy against JC virus in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Inflammatory Reaction in Progressive Multifocal Leukoencephalopathy: Harmful or Beneficial?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Determinants of survival in progressive multifocal leukoencephalopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Is maraviroc beneficial in paradoxical progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome management?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Randomized multicenter trial of natalizumab in acute MS relapses: clinical and MRI effects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Rituximab pharmacokinetics in patients with rheumatoid arthritis: B-cell levels do not correlate with clinical response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Treatment options for AIDS patients with progressive multifocal leukoencephalopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Successful resolution of progressive multifocal leukoencephalopathy after combination therapy with cidofovir and cytosine arabinoside

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Cytarabine therapy for progressive multifocal leukoencephalopathy in patients with AIDS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Prognostic value of JC virus load in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Remission of AIDS-associated progressive multifocal leukoencephalopathy after cidofovir therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Progressive multifocal leukoencephalopathy treated with cidofovir in HIV-infected patients receiving highly active anti-retroviral therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Cidofovir treatment of progressive multifocal leukoencephalopathy in a patient receiving highly active antiretroviral therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Response to cidofovir after failure of antiretroviral therapy alone in AIDS-associated progressive multifocal leukoencephalopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Monitoring the response of AIDS-related progressive multifocal leukoencephalopathy to HAART and cidofovir by PCR for JC virus DNA in the CSF.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: extended follow-up of an observational study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Progression of progressive multifocal leukoencephalopathy despite treatment with beta-interferon

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Topotecan in the treatment of acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Nonmyeloablative allogeneic stem cell transplantation for refractory Hodgkin's lymphoma complicated by interleukin-2 responsive progressive multifocal leukoencephalopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.164

Asymptomatic reactivation of JC virus in patients treated with natalizumab

31 March 2020

1 reference

12 December 2020

Failure of cytarabine and increased JC virus-DNA burden in the cerebrospinal fluid of patients with AIDS-related progressive multifocal leucoencephalopathy

1 reference

12 December 2020

Latency and reactivation of JC virus in peripheral blood of human immunodeficiency virus type 1-infected patients

1 reference

12 December 2020

Evidence that replication of human neurotropic JC virus DNA in glial cells is regulated by the sequence-specific single-stranded DNA-binding protein Pur alpha

1 reference

12 December 2020

A review of progressive multifocal leukoencephalopathy in persons with and without AIDS.

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus.

1 reference

12 December 2020

Successful treatment of aids related PML with HAART and cidofovir

1 reference

12 December 2020

Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal alpha(2-6)-linked sialic acids

1 reference

12 December 2020

Analysis of PCR as a tool for detection of JC virus DNA in cerebrospinal fluid for diagnosis of progressive multifocal leukoencephalopathy

1 reference

12 December 2020

The epidemiology of human polyomaviruses

1 reference

12 December 2020

10.1038/NRNEUROL.2010.164

Identifiers

DOI

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference